Evaluation of inclisiran versus placebo for the prevention of major adverse cardiovascular and limb events in patients undergoing percutaneous coronary intervention or peripheral endovascular intervention.
Contact phone
517-364-5760
Contact email
[email protected]
Principal investigator
Dr. Chad Link, DO
Trial Category
Heart & Vascular
Trial SubCategory
Cardiovascular Disease
Webform